About this episode

Henry Norton interviews Anat Shani about the LibAirty device and its impact on at-home airway clearance for chronic lung disease patients.

In this episode, host Henry Norton sits down with Anat Shani, CEO of Synchrony Medical, to talk about LibAirty™, the first FDA-cleared at-home airway clearance system and what it took to carry it from a COVID-era prototype to a US commercial launch. Key Topics The cystic fibrosis patient whose LibAirty device sustained her through a six-month, overseas transplant wait What airway clearance is, and why people with chronic lung disease need it every single day How LibAirty mimics a respiratory therapist using a guided-breathing vest synchronised with a coaching app Building inside the MEDX Xelerator venture studio and the Israeli Innovation Authority ecosystem Going from FDA 510(k) clearance to early US commercialisation Related Insights Why COVID accelerated the shift from hospital-based care into the home setting How tight feedback loops between engineers, clinicians and patients shaped the device Leading and reinventing yourself as a first-time founder through doubt and through conflict Why adherence, not just efficacy, is the real battleground in chronic respiratory care Core Challenges Chronic lung conditions like COPD, bronchiectasis and cystic fibrosis trap thick secretions…

More episodes of The Crux of Medtech

• The First Commercial Hire Makes or Breaks Your Startup with Brandon Allen · July 17, 2026 · 58 min
• Cleerly Is the Mammogram of the Heart with Jim Hartman · July 10, 2026 · 52 min
• Nobody Cares About Better, Cheaper, Faster with Jim Surek · July 8, 2026 · 59 min
• The Doctor Who Put a Heart Attack Detector in Your Pocket with Dr. Dave Albert · June 26, 2026 · 50 min

Explore listener stats, chart rankings, contacts and more on the The Crux of Medtech podcast page.